ABT-737, a BH3 Mimetic, Enhances the Therapeutic Effects of Ionizing Radiation in K-ras Mutant Non-Small Cell Lung Cancer Preclinical Model

키워드

참고문헌 (39)

1. Siegel RL, "Cancer statistics, 2021", CA Cancer J Clin, 71, pp.7~33 (2021)
2. Lehman M, "Improving therapeutic outcomes in non-small cell lung cancer not suitable for curative intent therapy—a review of the role of radiation therapy in an era of increasing systemic therapy options", Clin Oncol(R Coll Radiol), 28, pp.327~333 (2016)
3. Impicciatore G, "Nutlins and ionizing radiation in cancer therapy", Curr Pharm Des, 16, pp.1427~1442 (2010)
4. BischoffP, "Radiosensitising agents for the radiotherapy of cancer : advances in traditional and hypoxia targeted radiosensitisers", Expert Opin Ther Pat, 19, pp.643~662 (2009)
5. Galeaz C, "Radiation resistance : a matter of transcription factors", Front Oncol, 11, pp.662840~ (2021)
6. Adams JM, "The Bcl-2 protein family : arbiters of cell survival", Science, 281, pp.1322~1326 (1998)
7. Moretti L, "AT-101, a pan-Bcl-2 inhibitor, leads to radiosensitization of non-small cell lung cancer", J Thorac Oncol, 5, pp.680~687 (2010)
8. Haura EB, "Antiapoptotic signaling pathways in non-small-cell lung cancer : biology and therapeutic strategies", Clin Lung Cancer, 6, pp.113~122 (2004)
9. Borner MM, "Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer", Br J Cancer, 79, pp.952~958 (1999)
10. Mirkovic N, "Resistance to radiation-induced apoptosis in Bcl-2-expressing cells is reversed by depleting cellular thiols", Oncogene, 15, pp.1461~1470 (1997)
11. Kyprianou N, "bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells", Int J Cancer, 70, pp.341~348 (1997)
12. Baell JB, "Prospects for targeting the Bcl-2 family of proteins to develop novel cytotoxic drugs", Biochem Pharmacol, 64, pp.851~863 (2002)
13. Zhang L, "BH3 mimetics to improve cancer therapy;mechanisms and examples", Drug Resist Updat, 10, pp.207~217 (2007)
14. Oltersdorf T, "An inhibitor of Bcl-2 family proteins induces regression of solid tumours", Nature, 435, pp.677~681 (2005)
15. Lee EF, "Crystal structure of ABT-737 complexed with Bcl-xL : implications for selectivity of antagonists of the Bcl-2 family", Cell Death Differ, 14, pp.1711~1713 (2007)
16. Franken NA, "Clonogenic assay of cells in vitro", Nat Protoc, 1, pp.2315~2319 (2006)
17. Pietenpol JA, "Paradoxical inhibition of solid tumor cell growth by bcl2", Cancer Res, 54, pp.3714~3717 (1994)
18. Ho JN, "Bcl-XL and STAT3 mediate malignant actions of gamma-irradiation in lung cancer cells", Cancer Sci, 101, pp.1417~1423 (2010)
19. Lee JU, "Role of Bcl-2 family proteins(Bax, Bcl-2 and Bcl-X)on cellular susceptibility to radiation in pancreatic cancer cells", Eur J Cancer, 35, pp.1374~1380 (1999)
20. Li JY, "ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2and Bcl-xL", J Exp Clin Cancer Res, 31, pp.102~ (2012)
21. Li F, "Radiation enhances the invasion abilities of pulmonary adenocarcinoma cells via STAT3", Mol Med Rep, 7, pp.1883~1888 (2013)
22. Bjørkøy G, "p62", SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death, 2005, pp.171, 603~614
23. Karagounis IV, "Repression of the autophagic response sensitises lung cancer cells to radiation and chemotherapy", Br J Cancer, 115, pp.312~321 (2016)
24. Settembre C, "TFEB links autophagy to lysosomal biogenesis", Science, 332, pp.1429~1433 (2011)
25. Liu M, "Synergistic killing of lung cancer cells by cisplatin and radiation via autophagy and apoptosis", Oncol Lett, 7, pp.1903~1910 (2014)
26. 조국희, "Radiation-Induced Autophagy Contributes to Cell Death and Induces Apoptosis Partly in Malignant Glioma Cells", Cancer Research and Treatment, 47(2), pp.221~241 (2015), 대한암학회[DOI]
27. Chang L, "Cancer stem cells and signaling pathways in radioresistance", Oncotarget, 7, pp.11002~11017 (2016)
28. An J, "Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor", Oncogene, 26, pp.652~661 (2007)
29. Zerp SF, "AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2family members, activates the SAPK", JNK pathway and enhances radiation-induced apoptosis, 2009, pp.4, 47~
30. Wu H, "Ionizing radiation sensitizes breast cancer cells to Bcl-2 inhibitor, ABT-737, through regulating Mcl-1", Radiat Res, 182, pp.618~625 (2014)
31. Roberts AW, "Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition : results of a phase I study of navitoclax in patients with relapsed or refractory disease", J Clin Oncol, 30, pp.488~496 (2012)
32. Gandhi L, "Phase I study of Navitoclax(ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors", J Clin Oncol, 29, pp.909~916 (2011)
33. Gilormini M, "Preferential targeting of cancer stem cells in the radiosensitizing effect of ABT-737 on HNSCC", Oncotarget, 7, pp.16731~16744 (2016)
34. Wang H, "ABT-737 induces Bim expression via JNK signaling pathway and its effect on the radiation sensitivity of HeLa cells", PLoS One, 7, pp.e52483~ (2012)
35. Kim KW, "Combined Bcl-2", mammalian target of rapamycin inhibition leads to enhanced radiosensitization via induction of apoptosis and autophagy in nonsmall cell lung tumor xenograft model, 2009, pp.15, 6096~6105
36. Walrath JC, "Genetically engineered mouse models in cancer research", Adv Cancer Res, 106, pp.113~164 (2010)
37. Fushiki H, "Quantification of mouse pulmonary cancer models by microcomputed tomography imaging", Cancer Sci, 100, pp.1544~1549 (2009)
38. DuPage M, "Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase", Nat Protoc, 4, pp.1064~1072 (2009)
39. Park D, "Novel small-molecule inhibitors of Bcl-XL to treat lung cancer", Cancer Res, 73, pp.5485~5496 (2013)

관련 논문AI추천